熔点	155-158 ºC
水溶性	不溶

危险品标志	Xn
危险类别码	R40;R68
安全说明书	S36/37

来源	SDS样本
Alfa-Aesar	浏览或下载
Sigma-Aldrich	浏览或下载
TCI	浏览或下载

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates.Manfredi Rizzo et al.Current medical research and opinion, 23(5), 1103-1111 (2007-05-24) P450 CYP2C epoxygenase and CYP4A omega-hydroxylase mediate ciprofibrate-induced PPARalpha-dependent peroxisomal proliferation.Arnaldo Gatica et al.Journal of lipid research, 48(4), 924-934 (2007-01-20) Ciprofibrate, clofibric acid and respective glycinate derivatives. Effects of a four-week treatment on male lean and obese Zucker rats.Amelie Lupp et al.Arzneimittel-Forschung, 58(5), 225-241 (2008-07-01) Rosuvastatin and ciprofibrate in the treatment of dyslipidemia in patients with HIV.Hamilton Domingos et al.Arquivos brasileiros de cardiologia, 99(5), 997-1007 (2012-10-31) Flow cytometric assessment of peroxisome proliferation from frozen liver of fibrate-treated monkeys.Puntipa Kwanyuen et al.International journal of toxicology, 25(1), 41-47 (2006-03-03) Peroxisome proliferator-activated receptor alpha (PPARalpha) agonists induce constitutive androstane receptor (CAR) and cytochrome P450 2B in rat primary hepatocytes.Kosuke Saito et al.Drug metabolism and pharmacokinetics, 25(1), 108-111 (2010-03-09) Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome.György Paragh et al.British journal of clinical pharmacology, 61(6), 694-701 (2006-05-26) The atherogenic role of triglycerides and small, dense low density lipoproteins: impact of ciprofibrate therapy.M J Chapman et al.Atherosclerosis, 124 Suppl, S21-S28 (1996-07-01) Ciprofibrate quantification in human plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry for pharmacokinetic studies.Fabiana D Mendes et al.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 879(24), 2361-2368 (2011-07-19) Phosphorylation of peroxisome proliferator-activated receptor alpha in rat Fao cells and stimulation by ciprofibrate.P Passilly et al.Biochemical pharmacology, 58(6), 1001-1008 (1999-10-06) Gene expression profiles in rat liver slices exposed to hepatocarcinogenic enzyme inducers, peroxisome proliferators, and 17alpha-ethinylestradiol.Gisela Werle-Schneider et al.International journal of toxicology, 25(5), 379-395 (2006-08-31) Ciprofibrate regulation of rat hepatic bilirubin glucuronidation and UDP-glucuronosyltransferases expression.Jean-Marie Heydel et al.European journal of drug metabolism and pharmacokinetics, 37(4), 233-240 (2012-04-06) Peroxisome proliferator-activated receptor alpha agonists enhance cardiomyogenesis of mouse ES cells by utilization of a reactive oxygen species-dependent mechanism.Fatemeh Sharifpanah et al.Stem cells (Dayton, Ohio), 26(1), 64-71 (2007-10-24) Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease.Alessandro Antonelli et al.Experimental cell research, 317(11), 1527-1533 (2011-05-14) Efficacy and safety of ciprofibrate in hyperlipoproteinaemias.G Turpin et al.Atherosclerosis, 124 Suppl, S83-S87 (1996-07-01) [Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].Raúl A Espinosa et al.Investigacion clinica, 47(1), 35-48 (2006-03-28) Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells.Sung Hun Kim et al.Toxicology and applied pharmacology, 215(2), 198-207 (2006-04-18) Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal.Zakaria El Kebbaj et al.Endocrinology, 150(3), 1192-1201 (2008-10-25) Methods of chromatographic determination of medicines decreasing the level of cholesterol.Elzbieta Kublin et al.Acta poloniae pharmaceutica, 67(5), 455-461 (2010-09-30) Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver.Eliete J B Bighetti et al.Lipids in health and disease, 8, 50-50 (2009-11-26) PRIC320, a transcription coactivator, isolated from peroxisome proliferator-binding protein complex.Sailesh Surapureddi et al.Biochemical and biophysical research communications, 343(2), 535-543 (2006-03-24) Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotype.Valmore Bermúdez-Pirela et al.American journal of therapeutics, 14(2), 213-220 (2007-04-07) Ciglitazone induces caspase-independent apoptosis via p38-dependent AIF nuclear translocation in renal epithelial cells.Chae Hwa Kwon et al.Toxicology, 244(1), 13-24 (2007-12-18) Species-specific kinetics and zonation of hepatic DNA synthesis induced by ligands of PPARalpha.Abdullah Al Kholaifi et al.Toxicological sciences : an official journal of the Society of Toxicology, 104(1), 74-85 (2008-04-01) Pigment epithelium-derived factor is an angiogenesis and lipid regulator that activates peroxisome proliferator-activated receptor alpha.Chuhan Chung et al.Advances in experimental medicine and biology, 617, 591-597 (2008-05-24) Ciprofibrate--a profile.D J Betteridge Postgraduate medical journal, 69 Suppl 1, S42-S47 (1993-01-01) Transcriptional Regulation of Cytosolic Sulfotransferase 1C2 by Intermediates of the Cholesterol Biosynthetic Pathway in Primary Cultured Rat Hepatocytes.Elizabeth A Rondini et al.The Journal of pharmacology and experimental therapeutics, 355(3), 429-441 (2015-10-03) Subacute exposure to N-ethyl perfluorooctanesulfonamidoethanol results in the formation of perfluorooctanesulfonate and alters superoxide dismutase activity in female rats.Wei Xie et al.Archives of toxicology, 83(10), 909-924 (2009-06-23) Role of the p50 subunit of NF-kappaB in vitamin E-induced changes in mice treated with the peroxisome proliferator, ciprofibrate.Karen G Calfee-Mason et al.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 46(6), 2062-2073 (2008-03-14) Administration of ciprofibrate to lactating mothers induces PPARalpha-signaling pathway in the liver and kidney of suckling rats.Marco Fidaleo et al.Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 60(1), 33-41 (2008-04-25)

备注